Child Neurology Society's Brainstorm

Brainstorm is a production of the Child Neurology Society, Copyright 2021-2025, All Rights Reserved, Use by Permission Only. Hosted by: Kathryn Xixis, MD - Associate Professor of Neurology and Pediatrics, University of Virginia. Brainstorm discusses "High-Yield Facts for Physicians Short on Time" Disclaimer: This podcast aims to inform and educate healthcare professionals. It does not provide medical advice or replace clinical judgment. Feel free to explore the information presented here, but don't base your clinical decisions solely on it. Always consult qualified professionals and medical resources for specific patient care decisions.

Brainstorm is a production of the Child Neurology Society, Copyright 2021-2025, All Rights Reserved, Use by Permission Only. Hosted by: Kathryn Xixis, MD - Associate Professor of Neurology and Pediatrics, University of Virginia. Brainstorm discusses "High-Yield Facts for Physicians Short on Time" Disclaimer: This podcast aims to inform and educate healthcare professionals. It does not provide medical advice or replace clinical judgment. Feel free to explore the information presented here, but don't base your clinical decisions solely on it. Always consult qualified professionals and medical resources for specific patient care decisions.

Join Dr. Bonnie Kaur, Assistant Professor of Neurology and Pediatrics, as she dives into the world of neurofibromatosis type 1 (NF1). She discusses the evolution of treatments, including the groundbreaking MEK inhibitors, selumetinib and mirdametinib, which show promise in halting tumor growth. Dr. Kaur shares insights on eligibility, potential side effects, and the impressive results from recent clinical trials. She also highlights emerging therapies and resources for patients, making it a must-listen for those interested in NF1 advancements.

Join Jeffrey Strelzik, an expert in child neurology, as he dives into the complexities of neurofibromatosis type 1 (NF1). The discussion covers the genetics behind NF1 and the critical role of tumor suppressors. Strelzik outlines the latest diagnostic criteria and emphasizes the benefits of multidisciplinary care. He also addresses the range of potential complications, from neurologic issues to skin concerns. Lastly, the talk explores treatment options, including the use of MEK inhibitors for managing inoperable neurofibromas.

Brainstorm is a production of the Child Neurology Society, Copyright 2021-2025, All Rights Reserved, Use by Permission Only. Hosted by: Kathryn Xixis, MD - Associate Professor of Neurology and Pediatrics, University of Virginia Brainstorm discusses "High Yield Facts for Physicians Short on Time" Disclaimer: This podcast aims to inform and educate healthcare professionals. It does not provide medical advice or replace clinical judgment. Feel free to explore the information presented here, but don't base your clinical decisions solely on it. Always consult qualified professionals and medical resources for specific patient care decisions.

Brainstorm is a production of the Child Neurology Society, Copyright 2021-2025, All Rights Reserved, Use by Permission Only. Hosted by: Kathryn Xixis, MD - Associate Professor of Neurology and Pediatrics, University of Virginia Brainstorm discusses "High Yield Facts for Physicians Short on Time" Disclaimer: This podcast aims to inform and educate healthcare professionals. It does not provide medical advice or replace clinical judgment. Feel free to explore the information presented here, but don't base your clinical decisions solely on it. Always consult qualified professionals and medical resources for specific patient care decisions.

In this discussion, Dr. Howard Goodkin, a leading child neurologist and epileptologist, dives into the world of anti-seizure medications. He explains how these treatments work and emphasizes the difference between anti-seizure and anti-epileptic drugs. The podcast also highlights the critical impact of these medications on bone health and the necessity of folate monitoring for pregnant patients. Goodkin discusses long-term cognitive risks and advocates for precision medicine, showcasing cutting-edge strategies for rare epilepsy types like Dravet syndrome.

Brainstorm is a production of the Child Neurology Society, Copyright 2021-2025, All Rights Reserved, Use by Permission Only. Hosted by: Kathryn Xixis, MD - Asst. Professor of Neurology and Asst. Professor of Pediatrics, University of Virginia Brainstorm discusses "High Yield Facts for Physicians Short on Time" Disclaimer: This podcast aims to inform and educate healthcare professionals. It does not provide medical advice or replace clinical judgment. Feel free to explore the information presented here, but don't base your clinical decisions solely on it. Always consult qualified professionals and medical resources for specific patient care decisions.

Brainstorm is a production of the Child Neurology Society, Copyright 2021-2025, All Rights Reserved, Use by Permission Only. Hosted by: Kathryn Xixis, MD - Asst. Professor of Neurology and Asst. Professor of Pediatrics, University of Virginia Brainstorm discusses "High Yield Facts for Physicians Short on Time" Disclaimer: This podcast aims to inform and educate healthcare professionals. It does not provide medical advice or replace clinical judgment. Feel free to explore the information presented here, but don't base your clinical decisions solely on it. Always consult qualified professionals and medical resources for specific patient care decisions.

Aaron Nelson, MD, MBS, FAAP, FCNS, an expert in pediatric neurology and director of epilepsy at Bellevue Hospital, explores critical insights about first-time seizures in children. He breaks down the implications of abnormal neuron firing and common misconceptions surrounding seizures. Nelson discusses the importance of diagnostic evaluations, the balance between treating children and addressing parental concerns, and how rescue medications can be managed. He also highlights the value of seizure monitoring devices and education for families navigating this challenging experience.